This new Fact.MR study predicts the sales of platelet aggregation devices to rise at a phenomenal CAGR of 20% from 2022 to 2027. As such, the global platelet aggregation devices market is estimated to surge to over US$ 1 billion by the end of 2027.
High prevalence of blood disorders coupled with rising healthcare expenditure is expected to drive platelet aggregation device demand. Supportive government initiatives, rapid technological advancements, high incidence of cardiovascular disorders, and a growing aging population are other factors that will drive platelet aggregation devices market growth over the years to come.
This new platelet aggregation devices market research analysis by analysts at Fact.MR, a market research and competitive intelligence provider, has profiled key companies such as F. Hoffmann-La Roche Ltd., Instrumentation Laboratory, Haemonetics Corporation, Siemens Healthcare GmbH, SENTINEL CH. SpA, Werfen, Pathway Diagnostics Limited, Haemochrom Diagnostica GmbH, and TemGroup.
Get Sample PDF of This Research Report with Detailed Table of Content:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7657
New Market Participants Should Invest in R&D to Widen the Scope of Their Research
Upcoming market players could focus on expanding their research scope to create novel and innovative products. New market entrants could focus their research on thrombocyte aggregation, factors that inhibit platelet aggregation, and anti-platelet aggregation to create novel solutions and make a mark in the global landscape. Platelet-rich plasma is trending as a quick and effective treatment for orthopedic diseases, neurological diseases, sports injuries, and cardiothoracic diseases.
Companies in the platelet-rich plasma market are becoming aware of the benefits of platelet-rich plasma therapy for back pain. In December 2020, Basking Biosciences Inc., a private biopharmaceutical organization, announced that it had successfully raised US$ 5.4 million in a seed financing round. The company was working on exploring the role of vWF, a redundant mediator of platelet adhesion and aggregation, to develop a reversible thrombolytic therapy for acute ischemic stroke. Rising outbreaks of dengue & malaria and growing incidence of blood cancer are also expected to drive platelet aggregation system demand in this region.
Speak to Analyst:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=7657
Key Takeaways from Market Study
- At present, the global platelet aggregation devices market enjoys a valuation of US$ 421 million.
- Demand for platelet aggregation devices is anticipated to surge at an astounding CAGR of 20% over the next five years.
- By 2027, sales revenue of the platelet aggregation devices market is expected to be US$ 1.05 billion.
- Advancements in platelet aggregation system technologies, rising healthcare expenditure, growing geriatric population, increasing investments in healthcare R&D, and high prevalence of blood disorders are expected to favor platelet aggregation devices market growth.
- Sales of platelet aggregation systems are projected to rise at 20.7% CAGR and reach a valuation of US$ 500 million by the end of 2027.
- High cost of platelet aggregation systems, procedural limitations, and dearth of skilled professionals are anticipated to hurt platelet aggregation device growth to some extent.
- In 2022, the U.S. platelet aggregation devices market stands at US$ 105 million.
- Demand for platelet aggregation equipment in Germany is set to increase at a CAGR of 15% through 2027.
Quick Buy – Platelet Aggregation Devices Market Research Report:
https://www.factmr.com/checkout/7657
Key Segments in Platelet Aggregation Devices Industry Research
- By Product :
- Systems
- Reagents
- Consumables & Accessories
- By Application :
- Clinical
- Research
- By End User :
- Hospitals
- Diagnostic Laboratories
- Other End Users
- By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Winning Strategy
Platelet aggregation device manufacturers are expected to eye mergers, collaborations, acquisitions, and partnerships to widen their business scope and increase their revenue generation capacity. Companies are also expected to increase their investments in the research and development sector to create new innovative products and solutions for platelet aggregation.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global platelet aggregation devices market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.
The study divulges essential insights on the market on the basis of product (systems, reagents, consumables & accessories), application (clinical, research), and end user (hospitals, diagnostic laboratories, other end users), across five major regions (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).
Check out more related studies published by Fact.MR Research:
Arterial blood sampling systems market
https://www.factmr.com/report/arterial-blood-sampling-systems-market
Dual Antiplatelet Therapy Market
https://www.factmr.com/report/1002/dual-antiplatelet-therapy-market
Blood Bank Analyzers Market
https://www.factmr.com/report/3929/blood-bank-analyzers-market
Blood Testing Devices Market
https://www.factmr.com/report/2680/blood-testing-devices-market
Plastic Blood Bags Market
https://www.factmr.com/report/plastic-blood-bags-market
Automated Blood Tube Labeler & Specimen Transport Box Market
https://www.factmr.com/report/automated-blood-tube-labeler-and-specimen-transport-box-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158